Search

Your search keyword '"Ejlertsen, B"' showing total 683 results

Search Constraints

Start Over You searched for: Author "Ejlertsen, B" Remove constraint Author: "Ejlertsen, B"
683 results on '"Ejlertsen, B"'

Search Results

3. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

4. Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial

6. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

7. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

8. Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer:a Copenhagen Breast Cancer Genomics Study

9. Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer:a Copenhagen Breast Cancer Genomics Study

10. Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

11. Danish Breast Cancer Cooperative Group

13. Reply to ‘The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology’ by Kirova et al.

14. Symptoms of endocrine treatment and outcome in the BIG 1-98 study

20. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

21. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

22. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

26. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

27. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

28. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

29. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

30. Rates of re-excision and conversion to mastectomy after breast-conserving surgery with or without oncoplastic surgery: a nationwide population-based study

31. Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands

32. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

33. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

34. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

35. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

36. 83P Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+ HR+ breast cancer after trastuzumab-based therapy on patient outcomes

37. Rates of re-excision and conversion to mastectomy after breast-conserving surgery with or without oncoplastic surgery:a nationwide population-based study

38. Breast-contour preserving procedures for early-stage breast cancer:a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands

43. 83P Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+ HR+ breast cancer after trastuzumab-based therapy on patient outcomes

44. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

45. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

46. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

47. Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer

48. Symptoms of endocrine treatment and outcome in the BIG 1-98 study

Catalog

Books, media, physical & digital resources